Incidence of Drug Abuse in Revision Total Knee Arthroplasty Population

Abstract

Substance abuse can have strong negative impacts on surgical outcomes. Therefore, this study assessed the effects of drug abuse in total knee arthroplasty (TKA) patients. Specifically, we identified revision TKA (RTKA): (1) incidence, (2) causes, (3) time to revision, and (4) patient demographics in patients with a history of drug abuse. The Medicare database within the PearlDiver Supercomputer (Warsaw, IN) was queried to identify 2,159,221 TKAs performed between 2005 and 2012. Drug abuse was subdivided into cocaine, cannabis, opioids, sedatives/hypnotics/anxiolytics (SHA), amphetamines, and alcohol abusers. The effect of drug use on the incidence and cause for RTKA, time to revision, as well as patient demographics were correlated using multivariate, analysis of variance, and regression analyses. There was a significant increase in the number of primary TKAs in cocaine (p = 0.011), cannabis (p < 0.001), opioid (p < 0.001), SHA (p < 0.001), amphetamine (p < 0.001), and alcohol (p < 0.001) users. Amphetamine users had the fastest mean time to revision (691 days, standard deviation: 679 days). At 30-, 90-day, and 6-month postoperative, cocaine had the highest proportion of patients requiring RTKA (7, 12, and 20%, respectively), and at 1-year alcohol abusers (38%, p < 0.001). Infection was the most common cause of revision in all drug abuse/dependent cohorts. Age distributions varied significantly by group for primary TKA (p < 0.001). Comorbidity status was similar in all RTKA patients as determined by comparison of the mean Charlson comorbidity index scores (p = 0.091). Based on these results, drug abuse patients are at increased risk for RTKA. These high-risk patients should, therefore, be appropriately risk stratified and receive comprehensive postoperative pain management.

Keywords

knee - illicit - drug - arthroplasty - revision - replacement

• References

• 1 Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med 2005; 353 (18) 1945-1954
• 2 Wieser K, Zingg PO, Betz M, Neubauer G, Dora C. Total hip replacement in patients with history of illicit injecting drug use. Arch Orthop Trauma Surg 2012; 132 (07) 1037-1044
• 3 Lehman CR, Ries MD, Paiement GD, Davidson AB. Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty 2001; 16 (03) 330-335
• 4 Best MJ, Buller LT, Klika AK, Barsoum WK. Outcomes following primary total hip or knee arthroplasty in substance misusers. J Arthroplasty 2015; 30 (07) 1137-1141
• 5 Schulden JD, Thomas YF, Compton WM. Substance abuse in the United States: findings from recent epidemiologic studies. Curr Psychiatry Rep 2009; 11 (05) 353-359
• 6 Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64 (05) 566-576
• 7 Skolnick P. The opioid epidemic: crisis and solutions. Annu Rev Pharmacol Toxicol 2018; 58: 143-159
• 8 Hargan ED. Determiniation That a Public Health Emergency Exists. Available at: https://www.hhs.gov/sites/default/files/opioidPHEDeclaration-no-sig.pdf . Accessed August 26, 2018
• 9 Goesling J, Moser SE, Zaidi B. , et al. Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain 2016; 157 (06) 1259-1265
• 10 Kaafarani HM, Weil E, Wakeman S, Ring D. The opioid epidemic and new legislation in Massachusetts: time for a culture change in surgery?. Ann Surg 2017; 265 (04) 731-733
• 11 Zywiel MG, Stroh DA, Lee SY, Bonutti PM, Mont MA. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am 2011; 93 (21) 1988-1993
• 12 Pivec R, Issa K, Naziri Q, Kapadia BH, Bonutti PM, Mont MA. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. Int Orthop 2014; 38 (06) 1159-1165
• 13 Dufour R, Joshi AV, Pasquale MK. , et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract 2014; 14 (03) E106-E115
• 14 Bozic KJ, Lau E, Ong K. , et al. Risk factors for early revision after primary TKA in Medicare patients. Clin Orthop Relat Res 2014; 472 (01) 232-237
• 15 Bedard NA, DeMik DE, Dowdle SB, Callaghan JJ. Trends and risk factors for prolonged opioid use after unicompartmental knee arthroplasty. Bone Joint J 2018; 100-B (1, suppl A): 62-67
• 16 Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty 2018; 33 (01) 90-96
• 17 Elmallah RK, Cherian JJ, Pierce TP, Jauregui JJ, Harwin SF, Mont MA. New and common perioperative pain management techniques in total knee arthroplasty. J Knee Surg 2016; 29 (02) 169-178
• 18 Oliver J, Coggins C, Compton P. , et al; American Society for Pain Management Nursing. American Society for Pain Management Nursing position statement: pain management in patients with substance use disorders. J Addict Nurs 2012; 23 (03) 210-222
• 19 Ballantyne JC. Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions. Anesth Analg 2017; 125 (05) 1769-1778
• 20 Prater CD, Zylstra RG, Miller KE. Successful pain management for the recovering addicted patient. Prim Care Companion J Clin Psychiatry 2002; 4 (04) 125-131